Morgane Rolland




Viral Genetics Section, U.S. Military HIV Research Program, Walter Reed Army Institute of Research



Bai H, Li Y, Michael NL, Robb ML, Rolland M. (2019). The breadth of HIV-1 neutralizing antibodies depends on the conservation of key sites in their epitopes. PLoS computational biology, 15(6)

Rolland M. (2019). HIV-1 phylogenetics and vaccines. Current opinion in HIV and AIDS, 14(3)

Rolland M. (2019). Editorial: HIV-1 transmission and phylogenetics. Current opinion in HIV and AIDS, 14(3)

Robb ML, Eller LA, Rolland M. (2016). Acute HIV-1 Infection in Adults in East Africa and Thailand. The New England journal of medicine, 375(12)

Rolland M. (2016). HIV-1 immune evasion-a threat to effective vaccines?. Nature medicine, 22(6)

Rolland M, Modjarrad K. (2015). Multiple co-circulating HIV-1 subtypes in the Middle East and North Africa. AIDS (London, England), 29(11)

Janes H, Herbeck JT, Tovanabutra S, Thomas R, Frahm N, Duerr A, Hural J, Corey L, Self SG, Buchbinder SP, McElrath MJ, O'Connell RJ, Paris RM, Rerks-Ngarm S, Nitayaphan S, Pitisuttihum P, Kaewkungwal J, Robb ML, Michael NL, Mullins JI, Kim JH, Gilbert PB, Rolland M. (2015). HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders. Nature medicine, 21(10)

Dommaraju K, Kijak G, Carlson JM, Larsen BB, Tovanabutra S, Geraghty DE, Deng W, Maust BS, Edlefsen PT, Sanders-Buell E, Ratto-Kim S, deSouza MS, Rerks-Ngarm S, Nitayaphan S, Pitisuttihum P, Kaewkungwal J, O'Connell RJ, Robb ML, Michael NL, Mullins JI, Kim JH, Rolland M. (2014). CD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participants. PLoS One, 9(10)

Edlefsen PT, Gilbert PB, Rolland M. (2013). Sieve analysis in HIV-1 vaccine efficacy trials. Current opinion in HIV and AIDS, 8(5)

Rolland M, Manocheewa S, Swain JV, Lanxon-Cookson EC, Kim M, Westfall DH, Larsen BB, Gilbert PB, Mullins JI. (2013). HIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacity. Journal of virology, 87(10)

Rolland M, Edlefsen PT, Larsen BB, Tovanabutra S, Sanders-Buell E, Hertz T, deCamp AC, Carrico C, Menis S, Magaret CA, Ahmed H, Juraska M, Chen L, Konopa P, Nariya S, Stoddard JN, Wong K, Zhao H, Deng W, Maust BS, Bose M, Howell S, Bates A, Lazzaro M, O'Sullivan A, Lei E, Bradfield A, Ibitamuno G, Assawadarachai V, O'Connell RJ, deSouza MS, Nitayaphan S, Rerks-Ngarm S, Robb ML, McLellan JS, Georgiev I, Kwong PD, Carlson JM, Michael NL, Schief WR, Gilbert PB, Mullins JI, Kim JH. (2012). Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2. Nature, 490(7420)

Rolland M, Gilbert P. (2012). Evaluating immune correlates in HIV type 1 vaccine efficacy trials: what RV144 may provide. AIDS research and human retroviruses, 28(4)

Rolland M, Frahm N, Nickle DC, Jojic N, Deng W, Allen TM, Brander C, Heckerman DE, Mullins JI. (2011). Increased breadth and depth of cytotoxic T lymphocytes responses against HIV-1-B Nef by inclusion of epitope variant sequences. PLoS One, 6(3)

Rolland M, Tovanabutra S, deCamp AC, Frahm N, Gilbert PB, Sanders-Buell E, Heath L, Magaret CA, Bose M, Bradfield A, O'Sullivan A, Crossler J, Jones T, Nau M, Wong K, Zhao H, Raugi DN, Sorensen S, Stoddard JN, Maust BS, Deng W, Hural J, Dubey S, Michael NL, Shiver J, Corey L, Li F, Self SG, Kim J, Buchbinder S, Casimiro DR, Robertson MN, Duerr A, McElrath MJ, McCutchan FE, Mullins JI. (2011). Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nature medicine, 17(3)

Rolland M, Carlson JM, Manocheewa S, Swain JV, Lanxon-Cookson E, Deng W, Rousseau CM, Raugi DN, Learn GH, Maust BS, Coovadia H, Ndung'u T, Goulder PJ, Walker BD, Brander C, Heckerman DE, Mullins JI. (2010). Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics. PLoS One, 5(9)

Rolland M, Heckerman D, Deng W, Rousseau CM, Coovadia H, Bishop K, Goulder PJ, Walker BD, Brander C, Mullins JI. (2008). Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads. PLoS One, 3(1)

Rolland M, Nickle DC, Deng W, Frahm N, Brander C, Learn GH, Heckerman D, Jojic N, Jojic V, Walker BD, Mullins JI. (2007). Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins. PLoS One, 2(9)

Rolland M, Jensen MA, Nickle DC, Yan J, Learn GH, Heath L, Weiner D, Mullins JI. (2007). Reconstruction and function of ancestral center-of-tree human immunodeficiency virus type 1 proteins. Journal of virology, 81(16)

Rolland M, Brander C, Nickle DC, Herbeck JT, Gottlieb GS, Campbell MS, Maust BS, Mullins JI. (2007). HIV-1 over time: fitness loss or robustness gain?. Nature reviews. Microbiology, 5(9)

Rolland M, Nickle DC, Mullins JI. (2007). HIV-1 group M conserved elements vaccine. PLoS pathogens, 3(11)

Rolland M, Chauvineau C, Valas S, Mamoun RZ, Perrin G. (2004). Establishment and characterization of a goat synovial membrane cell line susceptible to small ruminant lentivirus infection. Journal of virological methods, 118(2)

Rolland M, Mooney J, Valas S, Perrin G, Mamoun RZ. (2002). Characterisation of an Irish caprine lentivirus strain--SRLV phylogeny revisited. Virus research, 85(1)